1. Home
  2. ABEO vs SCD Comparison

ABEO vs SCD Comparison

Compare ABEO & SCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

HOLD

Current Price

$5.06

Market Cap

281.0M

Sector

Health Care

ML Signal

HOLD

Logo LMP Capital and Income Fund Inc.

SCD

LMP Capital and Income Fund Inc.

HOLD

Current Price

$14.66

Market Cap

255.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABEO
SCD
Founded
1974
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
281.0M
255.4M
IPO Year
1980
N/A

Fundamental Metrics

Financial Performance
Metric
ABEO
SCD
Price
$5.06
$14.66
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$18.20
N/A
AVG Volume (30 Days)
1.6M
62.6K
Earning Date
11-12-2025
01-01-0001
Dividend Yield
N/A
9.63%
EPS Growth
N/A
N/A
EPS
1.29
N/A
Revenue
$400,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1,590.36
N/A
P/E Ratio
$4.17
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.93
$11.33
52 Week High
$7.54
$15.87

Technical Indicators

Market Signals
Indicator
ABEO
SCD
Relative Strength Index (RSI) 52.04 46.15
Support Level $4.53 $14.58
Resistance Level $5.61 $15.06
Average True Range (ATR) 0.27 0.16
MACD 0.08 0.02
Stochastic Oscillator 49.30 46.75

Price Performance

Historical Comparison
ABEO
SCD

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

About SCD LMP Capital and Income Fund Inc.

Lmp Capital & Income Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is total return with an emphasis on income. The fund invests in a broad range of equity and fixed-income securities of both the U.S. and foreign issuers. Its long-term investments consists of investments in common stocks, convertible preferred stocks, investments in underlying funds and master limited partnerships. Maximum investment in Sales in the IT sector, Cheniere Energy in the energy sector, Ares Management and U.S. Bancorp in the financials sector and Lennar in the consumer discretionary sector, and etc.

Share on Social Networks: